Clinical trial
Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients
NCT00333021 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00333021 |
|---|---|
| Title | Abdominal Surgery Study Of GSK576428 (Fondaparinux Sodium)In Japanese Patients |
| Official title | Clinical Evaluation of GSK576428 (Fondaparinux Sodium) in Prevention of Venous Thromboembolism (VTE) After Abdominal Surgery |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Venous Thromboembolism |
| Intervention type | Drug |
| Interventions | Fondaparinux sodium, GSK576428 |
| Enrollment | 127 |
| Start date | May 1, 2006 |
| Completion | Feb 1, 2007 |
| First posted | Jun 2, 2006 |
| Last update posted | Jul 10, 2009 |
| Countries | Japan |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: